-
261
Estimating the Health-Related Quality of Life Benefit of Prophylactic Treatment for COVID-19 in Immunocompromised People: A Multimethod Valuation Study
Published 2024-07-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
262
Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States
Published 2021-09-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
263
Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database
Published 2014-07-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
264
Montelukast Use and Patterns of Ambulatory Care among Asian versus Non-Asian Adult Patients with Asthma and/or Allergic Rhinitis in the United States
Published 2015-12-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
265
Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care
Published 2019-10-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article -
266
People and Families Affected by Glycogen Storage Disease Type Ia: An Analysis of Narrative Accounts Written by Individuals Living with GSDIa and Their Caregivers
Published 2025-04-01“…Journal of Health Economics and Outcomes Research…”
Get full text
Article